During the past decade, Cardiolink Clin Trials conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 2 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Cardiolink Clin Trials" are "Cardiovascular Disease" (2 trials), "Obesity" (2 trials), "Dyslipidemias" (1 trials), "Heart Failure With Preserved Ejection Fraction" (1 trials) and "Hyperlipoproteinemia" (1 trials). Many other conditions were trialed in "Cardiolink Clin Trials" in a lesser frequency.

Most popular intervention types in "Cardiolink Clin Trials" are "Drug" (6 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (6 trials), "Tirzepatide" (2 trials), "bococizumab (PF-04950615)" (2 trials), "LY3473329" (1 trials) and "LY3561774" (1 trials). Other intervention names were less common.

The vast majority of trials in "Cardiolink Clin Trials" are 6 trials for "All" genders.

Currently, there are NaN active trials in "Cardiolink Clin Trials". undefined are not yet recruiting, 4 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Cardiolink Clin Trials, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Cardiolink Clin Trials, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".